Usefulness of alternate prognostic serum and plasma markers for antiretroviral therapy for human immunodeficiency virus type 1 infection

Clinical and Vaccine Immunology

Volumn 15, Issue 1, 2008, Pages 154-158

  Kannangai, R ^a   Kandathil, A J ^a   Ebenezer, D L ^a   Mathai, E ^a   Prakash, A J ^a   Abraham, O C ^a   Sudarsanam, T D ^a   Pulimood, S A ^a   Selvakumar, R ^a   Job, V ^a   Sridharan, G ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ETHAMBUTOL; ISONIAZID; NEVIRAPINE; PRASTERONE SULFATE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; BIOLOGICAL MARKER; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INDIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; TREATMENT RESPONSE; TUBERCULOSIS; VIRUS LOAD; BLOOD; DEVELOPING COUNTRY; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD4-POSITIVE T-LYMPHOCYTES; DEHYDROEPIANDROSTERONE SULFATE; DEVELOPING COUNTRIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SERUM ALBUMIN; VIRAL LOAD;

EID: 43149099265     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00193-07     Document Type: Article

References (23)

1. Arinola, O. G., K. S. Adedapo, A. O. Kehinde, J. A. Olaniyi, and M. O. Akiibinu. 2004. Acute phase proteins, trace elements in asymptomatic human immunodeficiency virus infection in Nigerians. Afr. J. Med. Med. Sci. 33:317-322.
2. Christeff, N., N. Gherbi, O. Mammes, M. T. Dalle, S. Gharakhanian, O. Lortholary, J. C. Mechior, and E. A. Nunez. 1997. Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology 22(Suppl. 1):S11-S18.
3. Christeff, N., E. A. Nunez, and M. L. Gougeon. 2000. Changes in cortisol/DHEA ratio in HIV-infected men are related to immunological and metabolic perturbations leading to malnutrition and lipodystrophy. Ann. N. Y. Acad. Sci. 917:962-970.
4. Feldman, J. G., D. N. Burns, S. J. Gange, P. Bacchetti, M. Cohen, K. Anastos, M. Nowicki, R. Delapena, and P. Miotti. 2000. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study. AIDS 14:863-870.
5. Feldman, J. G., P. Goldwasser, S. Holman, J. DeHovitz, and H. Minkoff. 2003. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J. Acquir. Immune Defic. Syndr. 32:210-214.
6. Ferrando, S. J., J. G. Rabkin, and L. Poretsky. 1999. Dehydroepiandrosterone sulfate (DHEAS) and testosterone: relation to HIV illness stage and progression over one year. J. Acquir. Immune Defic. Syndr. 22:146-154.
7. Fraziano, M., G. Cappelli, M. Santucci, F. Mariani, M. Amicosante, M. Casarini, M., S. Giosue, A. Bisetti, and V. Colizzi. 1999. Expression of CCR5 is increased in human monocyte-derived macrophages and alveolar macrophages in the course of in vivo and in vitro Mycobacterium tuberculosis infection. AIDS Res. Hum. Retrovir. 15:869-874.
8. Joint United Nations Program on HIV/AIDS. 14 January 2007 accession date. AIDS epidemic update: December 2005. http://www.unaids.org/epi/ 2005/.
9. Lau, B., A. R. Sharrett, L. A. Kingsley, W. Post, F. J. Palella, B. Visscher, and S. J. Gange. 2006. C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch. Intern. Med. 166:64-70.
10. Loria, R. M., T. H. Inge, S. S. Cook, A. K. Szakal, and W. Regelson. 1988. Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J. Med. Virol. 26:301-314.
11. + T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Côte d'Ivoire. J. Med. Virol. 75:202-208.
12. + T-cell estimation. Clin. Diagn. Lab. Immunol. 12:1006-1009.
13. Kandathil, A. J., R. Kannangai, S. David, R. Selvakumar, V. Job, O. C. Abraham, and G. Sridharan. 2005. Human immnodeficiency virus infection and levels of dehydroepiandrosterone sulfate in plasma among Indians. Clin. Diagn. Lab. Immunol. 12:1117-1118.
14. + T-cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individuals. Clin. Diagn. Lab. Immunol. 8:1286-1288.
15. Mehta, S. H., J. Astemborski, T. R. Sterling, D. L. Thomas, and D. Vlahov. 2006. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res. Hum. Retrovir. 22:14-21.
16. Morris, L., T. Cilliers, H. Bredell, M. Phoswa, and D. Martin. 2001. CCR5 is the major co-receptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res. Hum. Retrovir. 17:697-701.
17. Morris, L., D. J. Martin, H. Bredell, S. N. Nyoka, L. Sacks, S. Pendle, L. Page-Shipp, C. L. Karp, T. R. Sterling, T. C. Quinn, and R. E. Chaisson. 2006. Human immunodeficiency virus 1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J. Infect. Dis. 187:1967-1971.
18. Noursadeghi, M., and R. F. Miller. 2005. Clinical value of C-reactive protein measurements in HIV-positive patients. Int. J. STD AIDS 16:438-441.
19. Olawumi, H. O., and P. O. Olatunji. 2006. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients. HIV Med. 7:351-355.
20. Resino, S., J. M. Bellón, S. Sánchez-Ramón, D. Gurbindo, and M. A. Muñóz-Fernandez. 2000. Clinical relevance of cytokine production in HIV-1 infection in children on antiretroviral therapy. Scand. J. Immunol. 52:634-640.
21. Schleicher, G. K., V. Herbert, A. Brink, S. Martin, R. Maraj, J. S. Galpin, and C. Feldman. 2005. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur. Respir. J. 25:688-692.
22. WHO. 14 January 2007 accession date. Progress on global access to HIV antiretroviral therapy: an update on "3 by 5." http://www.who.int/3by5/june2005execsummary.pdf.
23. Young, B., M. Gleeson, and A. W. Cripps. 1991. C-reactive protein: a critical review. Pathology 23:118-124.